Ricoh Jumps into mRNA Pharmaceuticals with U.S. Startup Deal

The Following Appears on asia.nikkei.com

Japanese printer maker targets capacity equivalent to 100m COVID shots by 2025

TOKYO — Ricoh will acquire U.S.-based biotechnology startup Elixirgen Scientific as early as July in a push to turn messenger RNA technology into a core business, Nikkei has learned.


Click Here to Read the Rest


SOURCE Nikkei

Ricoh USA, Inc. Named to ChannelE2E Top 100 Vertical Market MSPs: 2022 Edition